Talking to Patients About HCV Treatment

Slides:



Advertisements
Similar presentations
Hepatocirrhosis Liver cirrhosis.
Advertisements

By: Lisa Iacopetti Angela Bravo Dominic Cruz
Hepatitis C Treatment in Corrections: New Medicine, New Challenges
The effect of improved HCV diagnosis and treatment on public health The effect of improved HCV diagnosis and treatment on public health P Mathurin Hôpital.
Liver Disease and Thalassaemia George Constantinou.
Senate Health Care Committee Briefing: Hepatitis C Treatment Dan Lessler, MD Chief Medical Officer November 20, 2014.
Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C.
V.E.I.L. Liver Cancer Prevention. 1. Vaccination Birth dose + 2 Universal for those not already chronics Screening pregnant women Catch up vaccination.
Hepatitis C for the General Practitioner Morris Sherman MB BCh PhD FRCP(C) University of Toronto January 2013.
By: Taylor Lawrence.  Cirrhosis is a late stage of scarring (fibrosis) of the liver caused by many forms of liver diseases and conditions. This occurs.
LDV/SOF 90/400 mg qd Non-randomised Open-label N = 21 W12 SVR 12 NIAID SYNERGY GT4 Kohli A. Lancet Infect Dis 2015; Juky 15, ePub ahead of print ≥ 18 years.
Suppressing the Hepatitis C virus, Barriers to Care American Public Health Association APHA 143 rd Annual Meeting&Expo October 31-November 4,2015, Chicago,
Hepatitis C.
Hepatitis C in Egypt Seif Tamer Ahmed Naser. What is it? Liver disease caused by Hepatitis C virus Can range from mild illness lasting a few weeks to.
What is the contribution of alcohol to liver disease in the hepatitis C infected population. The epidemiological evidence Hamish Innes Research Fellow.
HBV. Overview of the Epidemiology of Hepatotropic Viruses.
Date of download: 9/17/2016 From: The Changing Burden of Hepatitis C Virus Infection in the United States: Model-Based Predictions Ann Intern Med. 2014;161(3):
Treatment of HBV/HCV Coinfection
Where Are We on the Path to Elimination of Chronic Hepatitis C?
A Providers Perspective: Management and Treatment of HCV in PWID
Addressing Viral Hepatitis
The changing landscape of hepatitis infection
Achieving WHO Recommendations for HCV in the European Union
Interactive Workshop.
Achieving WHO Recommendations for HCV Elimination in the Eastern Mediterranean Region I. Waked April 12, 2016.
Phase 3 Treatment-Naïve and Treatment-Experienced
On the Rise: Liver Cancer in Iowa Donald J. Hillebrand, MD.
THE APP THAT ALLOWS EVERY DOCTOR TO PRACTICE:
Chronic HCV Infection and CKD
Department of Veterans Affairs
A Review of the Critical Role of Imaging in Primary Liver Malignancy
HCV. The Spectrum of Hepatitis C Virus Infection: From Acute Infection to End-Stage Liver Disease.
Chronic Hepatitis C Virus Infection
Clinical Considerations in the Management of EGFR-Mutated Advanced NSCLC.
Starting Strong: Initial Evaluation of the Patient With HCV
The American Association for the Study of Liver Diseases and the Infectious Diseases Society of America Present HCV Guidance: Recommendations for Testing,
Treating Hep C with Novel Agents
HCV: Who Should We Screen and Why?
Achieving WHO Recommendations for HCV Elimination in the Western Pacific Region L. Wei April 13, 2016.
World Epidemiology. Are HIV and Other Chronic Diseases Models Applicable to Viral Hepatitis? Focus on HCV.
The HCV Revolution: Are You and Your Practice Ready?
Best Practices in Screening and Linkage to Care in Hepatitis C Virus
More Than Treatment.
HCV Screening.
Magnitude and Kinetics of Decrease in Liver Stiffness After Antiviral Therapy in Patients With Chronic Hepatitis C: A Systematic Review and Meta-analysis 
HBV Infection: Some Sobering Facts
Evaluation of the Patient With HCV Infection
What Does the Primary Care Physician Need to Know About Chronic Hepatitis C?
Engaging and Educating the Multidisciplinary Healthcare Team in HCV Care.
Case Study. Managing Medication and Adherence in SIHD: Partnering With the Patient to Improve Care.
Community Advocacy for HCV: Identify, Link to Care, and Treat to Prevent.
HCV Protease Inhibitors in Clinical Practice
From Symptom Management to Communication in Advanced GI Cancers
Risk of de novo Hepatocellular Carcinoma after HCV Treatment with Direct-Acting Antivirals Liver Cancer - DOI: / Fig. 1. Flowchart of included.
New Agents, New Regimens, New Strategies
Phase 3 Treatment-Naïve and Treatment-Experienced
A Sustained Viral Response Is Associated With Reduced Liver-Related Morbidity and Mortality in Patients With Hepatitis C Virus  Amit G. Singal, Michael.
Poor Response to Initial Therapy for Migraine
Division of Viral Hepatitis, CDC
Presented by: Jeanette Shabazz, PhD, NP-C
Hepatitis C: After the Diagnosis
A Guideline-Based Approach to HCV Care
HCV Protease Inhibitors in Clinical Practice
An Unmet Need.
Volume 138, Issue 2, Pages e6 (February 2010)
Sharon J. Hutchinson, Sheila M. Bird, David J. Goldberg 
Removing Barriers in the HCV Cascade of Care
Pei-Yuan Su,Yu-Chun Hsu,Shun-Sheng Wu,Wei-Wen Su,Maw-Soan Soon
Reversion of disease manifestations after HCV eradication
Multimodal Approaches to Cracking the Code in Low Back Pain
Presentation transcript:

Talking to Patients About HCV Treatment

3 All-Oral Therapies With Similar Efficacy for Chronic HCV Infection

It All Starts With a Conversation Be Prepared to Have It

Risk Factor-Based Screening Important, But Not Effective as a Single Strategy

Recommendations for the Identification of Chronic HCV Infection Among Persons Born 1945 to 1965

Recommendations for the Identification of Chronic HCV Infection Among Persons Born 1945 to 1965 (cont)

Treatment Can Stop the Progression of Liver Disease

Emphasize No More Interferon

Hepatitis C Can Be Cured

Cirrhosis Means Risk for Liver Cancer in Persons With Cirrhosis Even After SVR

Curing HCV Is About More Than the Liver

Treatment of HCV Infection Cure, Risk Reduction, and Decreased All-Cause Mortality

Fatigue in Persons With Chronic HCV Infection

Hepatic Fibrosis Cirrhosis or No Cirrhosis, That Is the Question

Serum Markers of Liver Fibrosis

Liver Elastogram Vibration-Controlled Transient Elastography

Prescriptions for HCV Antiviral Medications Must Be Approved by Insurance Companies

Adverse Effects of New HCV Antiviral Therapies Resetting Patient Expectations

Treating the Patient With Cirrhosis

"I'm cured. Can I drink alcohol?"

Medication Adherence Is More Important Than Ever

The First Visit for HCV Infection Take-Home Messages for Patients

Abbreviations

References

References (cont)

References (cont)

References (cont)

References (cont)